Strategies to Enable Remote Ingestion Monitoring, Patient Retention, and Quality Data COVID-19 has resulted in suspensions of an unprecedented number of clinical trials. Remote trials can be enabled with digital technologies that provide...
Read moreRx Radio: Embedding Sensors in Capsules with CEO of etectRx
It’s 2020 and embedding sensors in capsules is actually here. One company has recently received a breakthrough FDA clearance for their patented ingestible event marker, called the ID-Cap® System. That company is etectRx, and on this episode, we...
Read moreBreakthrough ID-Cap System from etectRx™ Selected to Measure Adherence to HIV Treatment in New University of Colorado Study
Announcement coincides with the issuance of two new U.S. Patents GAINESVILLE, Fla. (January 12, 2020) – etectRx™, Inc. (etectRx™), a privately-held digital health company, today announced the ID-Cap™ System is being utilized...
Read moreFuture Proof Pharmacy with Harry Travis – Pharmacy Podcast Nation
The original host of the Specialty Pharmacy Podcast and a frequent guest on the Pharmacy Podcast Network, Harry Travis, etectRx President & CEO, joins Todd Eury on FutureDose.tech discussing how to “Future Proof Pharmacy”. Listen...
Read moreetectRx Announces U.S. FDA Clearance of Novel Ingestible Event Marker
ID-Cap System Uses Advanced Wireless Technology to Reliably Track Ingestion Events GAINESVILLE, Fla. (December 9, 2019) – etectRx®, Inc. (etectRx), a privately-held digital health company, today announced U.S. Food and Drug Administration (FDA)...
Read moreFormative Qualitative Response of MSM with Substance Use to Digital Pills for PrEP Adherence
Presented by Dr. Peter Chai at IAPAC. Posted on June 14, 2019
2670
0
Technology You Ingest: Interview with Harry Travis
Harry Travis, president & CEO of etectRx, interviewed with the Orlando Entrepreneurs podcast to share the company story. Listen here at https://www.orlandoentrepreneurs.org/technology-you-ingest-interview-with-harry-travis/
Read moreetectRx, Inc. Announces Issuance of Additional U.S. Patents for Ingestible Medication Adherence System
GAINESVILLE, Fla. (June 10, 2019) – etectRx™ Inc., an early-stage digital health company, today announced that the United States Patent and Trademark Office has issued U.S. Patent 10,292,642 for an “Electronic Medication Compliance...
Read moreBioequivalence of Tenofovir Component of Tenofovir/Rilpivirine/Emtricitabine in Digital Pills
Presented by Dr. Peter Chai at IAPAC. Posted on June 6, 2019
2555
0
etectRx and Qualicaps Extend Strategic Relationship to Develop ID-Cap Technologies and Digital Pharma Market Opportunities
Qualicaps® to Display ID-Capsule™ Technology at INTERPHEX Week Japan GAINESVILLE, Fla. (June 6, 2019) – etectRx™ and Qualicaps® have extended their existing collaborative relationship to further develop the manufacturing and...
Read moreetectRx’s Innovative ID-Cap System Selected to Track Medication Ingestion in HIV Prevention Study
Digital Medicine System has the potential to provide clinicians with a new tool to track and manage adherence for HIV prevention therapy GAINESVILLE, Fla. (March 4, 2019) – etectRx™, a privately held digital health company, is pleased to...
Read moreDigital Pills May Be on the Horizon in Cancer Care
CEO of etectRx, Harry Travis, spoke with Oncology Live about digital pills, like the ID-Capsule, as a possibility for improving cancer care. Read more...
Read more